141 related articles for article (PubMed ID: 37749931)
1. Enhancing the production of recombinant adeno-associated virus in synthetic cell lines through systematic characterization.
Lu M; Lee Z; Lin YC; Irfanullah I; Cai W; Hu WS
Biotechnol Bioeng; 2024 Jan; 121(1):341-354. PubMed ID: 37749931
[TBL] [Abstract][Full Text] [Related]
2. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity.
Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS
Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988
[TBL] [Abstract][Full Text] [Related]
3. Construction of an rAAV Producer Cell Line through Synthetic Biology.
Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
[TBL] [Abstract][Full Text] [Related]
4. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
Lin YC; Lu M; Cai W; Hu WS
Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics kinetic analysis of recombinant adeno-associated virus production by plasmid transfection of HEK293 cells.
Lu M; Lee Z; Hu WS
Biotechnol Prog; 2024; 40(2):e3428. PubMed ID: 38289617
[TBL] [Abstract][Full Text] [Related]
6. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
7. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line.
Escandell J; Moura F; Carvalho SB; Silva RJS; Correia R; Roldão A; Gomes-Alves P; Alves PM
Biotechnol Bioeng; 2023 Sep; 120(9):2578-2587. PubMed ID: 37027346
[TBL] [Abstract][Full Text] [Related]
8. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
9. Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
Wang Y; Fu Q; Park SY; Lee YS; Park SY; Lee DY; Yoon S
Biotechnol Adv; 2024; 71():108322. PubMed ID: 38336188
[TBL] [Abstract][Full Text] [Related]
10. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
12. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
13. High throughput production, screening and analysis of adeno-associated viral vectors.
Drittanti L; Rivet C; Manceau P; Danos O; Vega M
Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
15. Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing.
Fu Q; Polanco A; Lee YS; Yoon S
Biotechnol Bioeng; 2023 Sep; 120(9):2601-2621. PubMed ID: 37126355
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
17. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
18. A rAAV2-producing yeast screening model to identify host proteins enhancing rAAV DNA replication and vector yield.
Aponte-Ubillus JJ; Barajas D; Peltier J; Bardliving C; Shamlou P; Gold D
Biotechnol Prog; 2019 Jan; 35(1):e2725. PubMed ID: 30298993
[TBL] [Abstract][Full Text] [Related]
19. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells.
Cao TM; Chen D; Barnard GC; Shen A
Biotechnol Bioeng; 2024 Jan; 121(1):395-402. PubMed ID: 37902721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
